Shortly after launching it, Doan’s was added to the portfolio and subsequently two years later in 2018 Amazon reached out to the Indian drug maker looking for companies that could launch Amazon-exclusive brands in the OTC space. Dr Reddy’s direct-to-consumer strategic priority gained the necessary traction and proved its viability.
